Schonfeld Strategic Advisors LLC Gemini Therapeutics, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $13.8 Billion
- Q3 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Gemini Therapeutics, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 100,000 shares of GMTX stock, worth $2.44 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100,000Holding current value
$2.44 Million% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding GMTX
# of Institutions
1Shares Held
2.44MCall Options Held
0Put Options Held
0About Gemini Therapeutics, Inc.
- Ticker GMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,244,500
- Market Cap $1.05B
- Description
- Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD). Its lead candidate is GEM103, a recombinant form of the human complement factor H protein to treat dry AMD patients. The company also develops GEM307 ...